1990s trial gave early danger signs for asthma drugs
Milwaukee Journal Sentinel The troubled history of asthma drugs known as long-acting beta-agonists goes back to the 1990s when a large clinical trial in Great Britain of the GlaxoSmithKline drug Serevent produced disturbing results. In that 16-week trial of 25,000 asthma … |
View full post on asthma – Google News